Pimasertib Uses, Dosage, Side Effects and more
Pimasertib is under investigation in clinical trial NCT01378377 (Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus).
| Attribute | Details |
|---|---|
| Trade Name | Pimasertib |
| Generic | Pimasertib |
| Pimasertib Other Names | Pimasertib |
| Type | |
| Formula | C15H15FIN3O3 |
| Weight | Average: 431.206 Monoisotopic: 431.01421 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
